Listen Live
Donate
 on air
Schedule

KCRW

Read & Explore

  • News
  • Entertainment
  • Food
  • Culture
  • Events

Listen

  • Live Radio
  • Music
  • Podcasts
  • Full Schedule

Information

  • About
  • Careers
  • Help / FAQ
  • Newsletters
  • Contact

Support

  • Become a Member
  • Become a VIP
  • Ways to Give
  • Shop
  • Member Perks

Become a Member

Donate to KCRW to support this cultural hub for music discovery, in-depth journalism, community storytelling, and free events. You'll become a KCRW Member and get a year of exclusive benefits.

DonateGive Monthly

Copyright 2025 KCRW. All rights reserved.

Report a Bug|Privacy Policy|Terms of Service|
Cookie Policy
|FCC Public Files

Back to To the Point

To the Point

Smart Drugs: The Quest for Getting an Edge

Let's face it, who doesn't want to be sharper, more alert, and able to ace anything you want to do without having to get much sleep? Now, in addition to Ritalin and Adderall, there's a new crop of over-the-counter drugs aimed at enhancing brain function, including Provigil and Modafinil.

  • rss
  • Share
By Warren Olney • Sep 4, 2015 • 32m Listen

Let's face it, who doesn't want to be sharper, more alert, and able to ace anything you want to do without having to get much sleep? Now, in addition to Ritalin and Adderall, there's a new crop of over-the-counter drugs aimed at enhancing brain function, including Provigil and Modafinil. Originally a narcolepsy drug Modafanil – or Moda -- is easy to obtain on college campuses now. Entrepreneurs, video gamers, office workers and musicians are taking it to give them an edge in a competitive world. But is it safe? Is this the beginning of a medicalized level doping of our minds? Are smart drugs miracle pills, pathways to addiction or just plain cheating?

  • https://images.ctfassets.net/2658fe8gbo8o/AvYox6VuEgcxpd20Xo9d3/769bca4fbf97bf022190f4813812c1e2/new-default.jpg?h=250

    Warren Olney

    former KCRW broadcaster

  • https://images.ctfassets.net/2658fe8gbo8o/AvYox6VuEgcxpd20Xo9d3/769bca4fbf97bf022190f4813812c1e2/new-default.jpg?h=250

    Jenny Hamel

    KCRW

  • https://images.ctfassets.net/2658fe8gbo8o/AvYox6VuEgcxpd20Xo9d3/769bca4fbf97bf022190f4813812c1e2/new-default.jpg?h=250

    Benjamin Gottlieb

    Reporter, Fill-in Host

  • https://images.ctfassets.net/2658fe8gbo8o/AvYox6VuEgcxpd20Xo9d3/769bca4fbf97bf022190f4813812c1e2/new-default.jpg?h=250

    Evan George

    Director of Content, News

  • KCRW placeholder

    Sydney Lupkin

    Vice News / MedPage Today

  • KCRW placeholder

    Jesse Lawler

    Axon Labs

  • KCRW placeholder

    James Giordano

    Georgetown University Medical Center

    NewsNationalPolitics
Back to To the Point